Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping By Flow Cytometry CD61 Test

The Immunophenotyping By Flow Cytometry CD61 Test helps diagnose and monitor blood disorders and cancers by analyzing cell characteristics. It is a key tool for hematologists and oncologists.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (minimum 2 mL) of whole blood in a Lavender Top (EDTA) tube and 3 mL (minimum 2 mL) of whole blood in a Green Top (Sodium Heparin) tube. Alternatively, 2 mL (minimum 1 mL) of bone marrow in a Green Top (Sodium Heparin) tube.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for this blood test. Please ensure the test request form includes the date, time, and relevant clinical details.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping By Flow Cytometry CD61 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Diagnosis of suspected hematological malignancies
  • ✓Monitoring treatment response in blood cancers
  • ✓Evaluation of unexplained bruising or bleeding
  • ✓Investigation of abnormal blood cell counts
  • ✓Characterization of blood cell populations
02

In plain language

What this test helps you understand

This test aids in the diagnosis, classification, and monitoring of hematological malignancies and other blood disorders by assessing the expression of the CD61 marker on blood cells.
The Immunophenotyping By Flow Cytometry CD61 Test is a diagnostic tool used to evaluate hematological malignancies and other blood disorders. It uses flow cytometry to analyze blood cells, providing important information for diagnosis and treatment planning. This test specifically measures the expression of CD61, a protein found on the surface of certain blood cells, including platelets and some types of cancer cells. Understanding CD61 levels can help healthcare providers identify specific types of blood cancers or monitor how well treatment is working. This test is particularly useful for patients with suspected or confirmed blood cancers, or those experiencing symptoms related to blood cell abnormalities.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for this blood test. Please ensure the test request form includes the date, time, and relevant clinical details.
Sample3 mL (minimum 2 mL) of whole blood in a Lavender Top (EDTA) tube and 3 mL (minimum 2 mL) of whole blood in a Green Top (Sodium Heparin) tube. Alternatively, 2 mL (minimum 1 mL) of bone marrow in a Green Top (Sodium Heparin) tube.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Test results must be interpreted by a qualified healthcare professional in conjunction with clinical findings and other diagnostic tests. This test is not a standalone diagnostic tool.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique used to identify and characterize cells based on the proteins (antigens) expressed on their surface or inside them. Flow cytometry is a common method used for immunophenotyping.
CD61 is a protein primarily found on platelets and certain types of cancer cells. Measuring its expression helps identify specific cell types and can be important in diagnosing and classifying blood disorders.
Samples must be shipped immediately at 18°C to 22°C. Do not refrigerate or freeze the samples.
No, fasting is not required for this test.
Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp